Baldwin Wealth Partners LLC MA Sells 2,956 Shares of Balchem Co. (NASDAQ:BCPC)

Baldwin Wealth Partners LLC MA reduced its position in Balchem Co. (NASDAQ:BCPC - Free Report) by 55.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,337 shares of the basic materials company's stock after selling 2,956 shares during the quarter. Baldwin Wealth Partners LLC MA's holdings in Balchem were worth $381,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of BCPC. Westside Investment Management Inc. bought a new position in Balchem in the third quarter worth approximately $27,000. nVerses Capital LLC acquired a new stake in Balchem in the 3rd quarter valued at $35,000. Wilmington Savings Fund Society FSB bought a new stake in Balchem during the 3rd quarter valued at $35,000. Blue Trust Inc. raised its holdings in Balchem by 642.5% during the third quarter. Blue Trust Inc. now owns 839 shares of the basic materials company's stock worth $148,000 after buying an additional 726 shares during the last quarter. Finally, GAMMA Investing LLC lifted its stake in shares of Balchem by 73.4% in the third quarter. GAMMA Investing LLC now owns 841 shares of the basic materials company's stock valued at $148,000 after buying an additional 356 shares in the last quarter. Institutional investors and hedge funds own 87.91% of the company's stock.

Balchem Stock Performance

Shares of NASDAQ BCPC traded up $0.14 during mid-day trading on Tuesday, reaching $161.03. 62,206 shares of the company's stock were exchanged, compared to its average volume of 127,218. Balchem Co. has a 52 week low of $137.69 and a 52 week high of $186.03. The firm has a 50-day moving average price of $168.26 and a two-hundred day moving average price of $170.87. The firm has a market capitalization of $5.24 billion, a price-to-earnings ratio of 43.29, a price-to-earnings-growth ratio of 4.36 and a beta of 0.69. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.98 and a quick ratio of 1.90.

Balchem Increases Dividend

The company also recently disclosed an annual dividend, which was paid on Friday, January 17th. Shareholders of record on Thursday, December 26th were issued a dividend of $0.87 per share. This represents a yield of 0.4%. This is a positive change from Balchem's previous annual dividend of $0.79. The ex-dividend date was Thursday, December 26th. Balchem's dividend payout ratio is 23.39%.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on BCPC shares. HC Wainwright raised their price target on shares of Balchem from $185.00 to $190.00 and gave the company a "buy" rating in a research report on Monday, November 4th. StockNews.com raised Balchem from a "hold" rating to a "buy" rating in a research report on Monday, October 28th.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.